Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Impact of genetic targets on therapy in head and neck squamous cell carcinoma.

Chaikhoutdinov I, Goldenberg D.

Adv Exp Med Biol. 2013;779:165-77. doi: 10.1007/978-1-4614-6176-0_7. Review.

PMID:
23288639
2.

[Cancer stem cell phenotypes and miRNA: therapeutic targets in head and neck squamous cell carcinoma].

Coordes A, Zhifeng S, Sangvatanakul V, Qian X, Lenarz M, Kaufmann AM, Albers AE.

HNO. 2014 Dec;62(12):867-72. doi: 10.1007/s00106-014-2931-4. Review. German.

PMID:
25337967
3.

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.

Matta A, Ralhan R.

Head Neck Oncol. 2009 Mar 2;1:6. doi: 10.1186/1758-3284-1-6. Review.

4.

The molecular pathogenesis of head and neck squamous cell carcinoma.

Rothenberg SM, Ellisen LW.

J Clin Invest. 2012 Jun;122(6):1951-7. Review.

5.

Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.

Glazer CA, Chang SS, Ha PK, Califano JA.

Oral Oncol. 2009 Apr-May;45(4-5):440-6. doi: 10.1016/j.oraloncology.2008.05.013. Epub 2008 Jul 31. Review.

PMID:
18674958
6.

Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation.

Howard JD, Lu B, Chung CH.

Oral Oncol. 2012 Jan;48(1):10-7. doi: 10.1016/j.oraloncology.2011.09.013. Epub 2011 Oct 22. Review.

PMID:
22020057
7.

Evaluation of non-coding RNAs as potential targets in head and neck squamous cell carcinoma cancer stem cells.

Rahimy E, Kuo SZ, Ongkeko WM.

Curr Drug Targets. 2014;15(13):1247-60. Review.

PMID:
25341422
8.

Genomic sequencing and precision medicine in head and neck cancers.

Hoesli RC, Ludwig ML, Michmerhuizen NL, Rosko AJ, Spector ME, Brenner JC, Birkeland AC.

Eur J Surg Oncol. 2017 May;43(5):884-892. doi: 10.1016/j.ejso.2016.12.002. Epub 2016 Dec 15. Review.

PMID:
28034498
9.

New promising molecular targets in head and neck squamous cell carcinoma.

Bauman JE, Michel LS, Chung CH.

Curr Opin Oncol. 2012 May;24(3):235-42. doi: 10.1097/CCO.0b013e3283517920. Review.

PMID:
22327839
10.

Molecular profiling of head and neck tumors.

Sotiriou C, Lothaire P, Dequanter D, Cardoso F, Awada A.

Curr Opin Oncol. 2004 May;16(3):211-4. Review.

PMID:
15069314
11.

Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.

Ausoni S, Boscolo-Rizzo P, Singh B, Da Mosto MC, Spinato G, Tirelli G, Spinato R, Azzarello G.

Cancer Metastasis Rev. 2016 Sep;35(3):413-26. doi: 10.1007/s10555-016-9625-1. Review.

PMID:
27194534
12.

Defining the genomic landscape of head and neck cancers through next-generation sequencing.

Rizzo G, Black M, Mymryk JS, Barrett JW, Nichols AC.

Oral Dis. 2015 Jan;21(1):e11-24. doi: 10.1111/odi.12246. Epub 2014 Apr 30. Review.

PMID:
24725020
13.

p53-based therapeutics for head and neck squamous cell carcinoma.

Tassone P, Old M, Teknos TN, Pan Q.

Oral Oncol. 2013 Aug;49(8):733-7. doi: 10.1016/j.oraloncology.2013.03.447. Epub 2013 Apr 25. Review.

14.

Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.

Bowles DW, McDermott JD, Jimeno A.

Future Oncol. 2014 May;10(6):1065-80. doi: 10.2217/fon.14.18. Review.

PMID:
24941990
15.

Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.

Harari PM, Wheeler DL, Grandis JR.

Semin Radiat Oncol. 2009 Jan;19(1):63-8. doi: 10.1016/j.semradonc.2008.09.009. Review.

16.

miRNAs in head and neck cancer revisited.

Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C.

Cell Oncol (Dordr). 2013 Feb;36(1):1-7. doi: 10.1007/s13402-012-0122-4. Epub 2013 Jan 22. Review.

PMID:
23338821
17.

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

Giefing M, Wierzbicka M, Szyfter K, Brenner JC, Braakhuis BJ, Brakenhoff RH, Bradford CR, Sorensen JA, Rinaldo A, Rodrigo JP, Takes RP, Ferlito A.

Eur J Cancer. 2016 Mar;55:147-57. doi: 10.1016/j.ejca.2015.10.070. Epub 2016 Feb 4. Review.

18.

Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.

Kanazawa T, Misawa K, Carey TE.

Expert Opin Ther Targets. 2010 Mar;14(3):289-302. doi: 10.1517/14728221003598922. Review.

PMID:
20148716
19.

Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.

Gollin SM.

Genes Chromosomes Cancer. 2014 Dec;53(12):972-90. doi: 10.1002/gcc.22214. Epub 2014 Sep 3. Review.

PMID:
25183546
20.

Integration of molecular targeted therapy with radiation in head and neck cancer.

Du Y, Peyser ND, Grandis JR.

Pharmacol Ther. 2014 Apr;142(1):88-98. doi: 10.1016/j.pharmthera.2013.11.007. Epub 2013 Nov 23. Review.

PMID:
24280066

Supplemental Content

Support Center